4.4 Article

Human germline nuclear transfer to overcome mitochondrial disease and failed fertilization after ICSI

Journal

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
Volume 39, Issue 3, Pages 609-618

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10815-022-02401-7

Keywords

Pronuclear transfer; Spindle transfer; Mitochondrial DNA disease; Female infertility; Fertilization failure

Funding

  1. China Scholarship Council (CSC) [201506160059]
  2. Special Research Fund from Ghent University (Bijzonder Onderzoeksfonds, BOF) [01SC2916, 01SC9518]
  3. Ferring Pharmaceuticals
  4. FWO-Vlaanderen (Flemish fund for scientific research) [G051017N, G051516N, G1507816N, 11C2821N, 1S80222N]

Ask authors/readers for more resources

This study aims to explore the application of human nuclear transfer (NT) in treating mitochondrial disease transmission and failed fertilization. The experiments confirmed the effectiveness of NT in reducing mitochondrial transmission and demonstrated for the first time that NT can enable successful fertilization in cases of failed fertilization.
Purpose Providing additional insights on the efficacy of human nuclear transfer (NT). Here, and earlier, NT has been applied to minimize transmission risk of mitochondrial DNA (mtDNA) diseases. NT has also been proposed for treating infertility, but it is still unclear which infertility indications would benefit. In this work, we therefore additionally assess the applicability of NT to overcome failed fertilization. Methods Patient 1 carries a homoplasmic mtDNA mutation (m.11778G > A). Seventeen metaphase II (MII) oocytes underwent pre-implantation genetic testing (PGT), while five MII oocytes were used for spindle transfer (ST), and one in vitro matured (IVM) metaphase I oocyte underwent early pronuclear transfer (ePNT). Patients 2-3 experienced multiple failed intracytoplasmic sperm injection (ICSI) and ICSI-assisted oocyte activation (AOA) cycles. For these patients, the obtained MII oocytes underwent an additional ICSI-AOA cycle, while the IVM oocytes were subjected to ST. Results For patient 1, PGT-M confirmed mutation loads close to 100%. All ST-reconstructed oocytes fertilized and cleaved, of which one progressed to the blastocyst stage. The reconstructed ePNT-zygote reached the morula stage. These samples showed an average mtDNA carry-over rate of 2.9% +/- 0.8%, confirming the feasibility of NT to reduce mtDNA transmission. For patient 2-3 displaying fertilization failure, ST resulted in, respectively, 4/5 and 6/6 fertilized oocytes, providing evidence, for the first time, that NT can enable successful fertilization in this patient population. Conclusion Our study showcases the repertoire of disorders for which NT can be beneficial, to overcome either mitochondrial disease transmission or failed fertilization after ICSI-AOA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available